SP5M002 Inj.
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SP5M002 Inj., covering 2024-05-03 to 2024-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Pivotal Study to Evaluate Efficacy and Safety of SP5M002 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee Osteoarthritis [Phase 3]